Found 19 results
Author Title Type [ Year(Asc)]
Filters: Author is Sheetz, MJ  [Clear All Filters]
2006
L. P. Aiello, Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., and Milton, R. C., Effect of Ruboxistaurin on Diabetic Macular Edema and Visual Loss: Integrated Analysis of the PKC-DRS and PKC-DRS2, in American Diabetes Association 66th Scientific Sessions, Washington, DC, 2006.
P. M. Dodson, Aiello, L. P., Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., PKC-DRS, R. C. Milton for, and Groups, P. K. C. - D. R. S. Study, Effect of Ruboxistaurin on diabetic macular edema and visual loss: Integrated analysis of the PKC-DRS and PKC-DRS2, 2006.
R. P. Danis, Sheetz, M. J., Aiello, L. P., Davis, M. D., Milton, R. C., Girach, A., Zhi, X., and Group, V. L. for the, Effect of Ruboxistaurin on reversibility of vision loss in nonproliferative diabetic retinopathy patients, 2006.
R. P. Danis, Girach, A., Aiello, L. P., Davis, M. D., Milton, R. C., Sheetz, M. J., Lin, T. E., Zhi, X., and Group, V. L. for the, The Effect of the Oral PKC b Inhibitor, Ruboxistaurin, on Visual Loss and Diabetic Macular Edema, in 24th Annual American society of Retinal Specialists and the 6th Annual European Vitreoretinal Society Meeting, Cannes, France, 2006.
A. Girach, Aiello, L. P., Davis, M. D., Milton, R. C., Sheetz, M. J., Zhi, X., and Group, V. L. for the, Effect of the oral protein Kinase C b Inhibitor, Ruboxistaurin, on visual acuity in the PKC-DRS2 study, 2006.
L. Vignati, Sheetz, M. J., Girach, A., Zhi, X., Davis, M. D., and Milton, R. C., Effect of the Oral Protein Kinase C b Inhibitor, Ruboxistaurin, on Visual Acuity in the PKC-DRS2 Study, 2006.
A. Brucker, Aiello, L. P., Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., and Group, R. C. Milton for, Effect of the orally administered PKC b Inhibitor, Ruboxistaurin, on sustained moderate visual loss in the PKC-DRS2 Study, 2006.
L. P. Aiello, Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., and Milton, R., Effect of the Orally Administered PKC b Inhibitor, Ruboxistaurin, on Sustained Moderate Visual Loss in the PKC-DRS2 Study, in 29th Annual Meeting of the Macula Society, San Diego, CA, 2006.
2005
L. P. Aiello, Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., and Milton, R. C., Baseline Patient Characteristics in the PKC-DRS2 Trial: The Effect of The PKC-b Inhibitor Ruboxistaurin on Moderate Visual Loss, in 13th Congress of the European Society of Ophthalmology (SOE) and the 103rd Congress of German Society of Ophthalmology (DOG), Berlin, Germany, 2005.
M. J. Sheetz, Aiello, L. P., Davis, M. D., Milton, R. C., Hu, K., Girach, A., and Vignati, L., The Effect of Riboxistaurin (RBX) on Visual Acuity Loss Due to Diabetic Macular Edema (DME), in 15th Scientific Meeting of the Eye Complications Study Group of the European Association for the Study of Diabetes (EASDec), Coimbra, Portugal, 2005.
L. P. Aiello, Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., and Milton, R. C., The Effect of the PKC b Inhibitor Ruboxistaurin on Moderate Visual Loss: The PKC-DRS2 Trial Baseline Characteristics and Preliminary Results, in American Academy of Ophthalmology, Chicago, IL, 2005.